{
  "claims": [
    {
      "claim_id": "C01",
      "claim": "Intratumoral mRNA vaccination sensitizes tumors to anti‑PD‑L1 checkpoint blockade.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "The paper investigates whether intratumoral delivery of an mRNA vaccine can create an interferon‑rich inflammatory state that improves sensitivity to anti‑PD‑L1 therapy.",
          "line_ref": "L11"
        },
        {
          "quote": "Broader antigen display after intratumoral mRNA vaccination",
          "line_ref": "L28"
        }
      ],
      "caveat": "Mechanistic data are derived from mouse models; human causality has not been experimentally proven."
    },
    {
      "claim_id": "C02",
      "claim": "mRNA vaccination expands the tumor immunopeptidome, increasing antigen presentation on MHC‑I molecules.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "Broader antigen display after intratumoral mRNA vaccination",
          "line_ref": "L28"
        },
        {
          "quote": "Strong expansion of MHC‑I‑presented landscape",
          "line_ref": "L29"
        }
      ],
      "caveat": "Antigen expansion was observed in specific murine tumor models and may not be universal across all cancer types."
    },
    {
      "claim_id": "C03",
      "claim": "Patients previously vaccinated with SARS‑CoV‑2 mRNA vaccines show improved survival when treated with ICIs.",
      "strength": "moderate",
      "evidence": [
        {
          "quote": "Vaccinated subgroup had improved survival under ICI treatment",
          "line_ref": "L30"
        },
        {
          "quote": "Combined intervention improves tumor control in mice and aligns with better outcomes in the retrospective human cohort",
          "line_ref": "L46"
        }
      ],
      "caveat": "The human analysis is retrospective and non‑randomized, introducing potential confounding variables."
    },
    {
      "claim_id": "C04",
      "claim": "Intratumoral mRNA vaccination induces a strong type I interferon response within the tumor microenvironment.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "Marked induction after mRNA vaccination in tumors",
          "line_ref": "L31"
        },
        {
          "quote": "Intratumoral mRNA vaccination triggers local innate sensing and type I interferon signaling.",
          "line_ref": "L42"
        }
      ],
      "caveat": "Interferon induction was measured in tumor tissue of mice; direct measurement in patients was not performed."
    },
    {
      "claim_id": "C05",
      "claim": "Vaccination up‑regulates PD‑L1 expression and increases intratumoral CD8⁺ T‑cell density, enhancing checkpoint targetability.",
      "strength": "moderate",
      "evidence": [
        {
          "quote": "Checkpoint axis became more targetable",
          "line_ref": "L32"
        },
        {
          "quote": "Increased immune infiltration with combination therapy",
          "line_ref": "L33"
        }
      ],
      "caveat": "Expression changes are reported as relative fold‑changes and their functional impact on therapy response remains to be quantified."
    }
  ]
}